Cargando…

One-year follow-up of treatment outcomes and patient opinions of Retraining and Control Therapy (ReACT) for pediatric functional seizures

Retraining and Control Therapy (ReACT), a short-term treatment for pediatric functional seizures (FS), has been demonstrated to improve FS in children compared to supportive therapy. However, long-term maintenance of FS-reduction after ReACT is unclear. This study aims to assess seizure frequency 1 ...

Descripción completa

Detalles Bibliográficos
Autores principales: Stager, Lindsay, Szaflarski, Jerzy P., Fobian, Aaron D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633863/
https://www.ncbi.nlm.nih.gov/pubmed/34877517
http://dx.doi.org/10.1016/j.ebr.2021.100503
_version_ 1784608014716633088
author Stager, Lindsay
Szaflarski, Jerzy P.
Fobian, Aaron D.
author_facet Stager, Lindsay
Szaflarski, Jerzy P.
Fobian, Aaron D.
author_sort Stager, Lindsay
collection PubMed
description Retraining and Control Therapy (ReACT), a short-term treatment for pediatric functional seizures (FS), has been demonstrated to improve FS in children compared to supportive therapy. However, long-term maintenance of FS-reduction after ReACT is unclear. This study aims to assess seizure frequency 1 year after ReACT and determine patient and parents’ opinions of ReACT. Children with functional seizures who previously completed ReACT and their parents were asked to report 30-day FS frequency 1 year after completing ReACT. They also reported if ReACT was helpful. Paired samples t-tests were used to compare FS frequency before ReACT to 1 year after and to compare FS frequency in 30 days after ReACT to 1 year after. Fourteen children (Mean(age) = 15.43) and their parents participated. Seven-day FS frequency for patients at 1-year follow-up (Mean = 0.15) was significantly lower than 7-day FS frequency pre-ReACT (Mean = 5.62; p = 0.005). No differences were found when comparing FS frequency during 30 days post-ReACT (Mean = 0.29) and in 30 days before 1-year follow-up (Mean = 0.71). This study confirms long-term maintenance of FS-reduction after ReACT and supports the efficacy of targeting FS directly as opposed to mood or stress for reducing FS. Additionally, children and parents believe ReACT is beneficial.
format Online
Article
Text
id pubmed-8633863
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-86338632021-12-06 One-year follow-up of treatment outcomes and patient opinions of Retraining and Control Therapy (ReACT) for pediatric functional seizures Stager, Lindsay Szaflarski, Jerzy P. Fobian, Aaron D. Epilepsy Behav Rep Article Retraining and Control Therapy (ReACT), a short-term treatment for pediatric functional seizures (FS), has been demonstrated to improve FS in children compared to supportive therapy. However, long-term maintenance of FS-reduction after ReACT is unclear. This study aims to assess seizure frequency 1 year after ReACT and determine patient and parents’ opinions of ReACT. Children with functional seizures who previously completed ReACT and their parents were asked to report 30-day FS frequency 1 year after completing ReACT. They also reported if ReACT was helpful. Paired samples t-tests were used to compare FS frequency before ReACT to 1 year after and to compare FS frequency in 30 days after ReACT to 1 year after. Fourteen children (Mean(age) = 15.43) and their parents participated. Seven-day FS frequency for patients at 1-year follow-up (Mean = 0.15) was significantly lower than 7-day FS frequency pre-ReACT (Mean = 5.62; p = 0.005). No differences were found when comparing FS frequency during 30 days post-ReACT (Mean = 0.29) and in 30 days before 1-year follow-up (Mean = 0.71). This study confirms long-term maintenance of FS-reduction after ReACT and supports the efficacy of targeting FS directly as opposed to mood or stress for reducing FS. Additionally, children and parents believe ReACT is beneficial. Elsevier 2021-11-09 /pmc/articles/PMC8633863/ /pubmed/34877517 http://dx.doi.org/10.1016/j.ebr.2021.100503 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Stager, Lindsay
Szaflarski, Jerzy P.
Fobian, Aaron D.
One-year follow-up of treatment outcomes and patient opinions of Retraining and Control Therapy (ReACT) for pediatric functional seizures
title One-year follow-up of treatment outcomes and patient opinions of Retraining and Control Therapy (ReACT) for pediatric functional seizures
title_full One-year follow-up of treatment outcomes and patient opinions of Retraining and Control Therapy (ReACT) for pediatric functional seizures
title_fullStr One-year follow-up of treatment outcomes and patient opinions of Retraining and Control Therapy (ReACT) for pediatric functional seizures
title_full_unstemmed One-year follow-up of treatment outcomes and patient opinions of Retraining and Control Therapy (ReACT) for pediatric functional seizures
title_short One-year follow-up of treatment outcomes and patient opinions of Retraining and Control Therapy (ReACT) for pediatric functional seizures
title_sort one-year follow-up of treatment outcomes and patient opinions of retraining and control therapy (react) for pediatric functional seizures
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633863/
https://www.ncbi.nlm.nih.gov/pubmed/34877517
http://dx.doi.org/10.1016/j.ebr.2021.100503
work_keys_str_mv AT stagerlindsay oneyearfollowupoftreatmentoutcomesandpatientopinionsofretrainingandcontroltherapyreactforpediatricfunctionalseizures
AT szaflarskijerzyp oneyearfollowupoftreatmentoutcomesandpatientopinionsofretrainingandcontroltherapyreactforpediatricfunctionalseizures
AT fobianaarond oneyearfollowupoftreatmentoutcomesandpatientopinionsofretrainingandcontroltherapyreactforpediatricfunctionalseizures